We are proud to announce that PhenoPath is now a Quest Diagnostics Company.


The knowns and the unknowns in HER2 testing in breast cancer

By Gown AM, Goldstein LC.
Am J Clin Pathol. 2011 Jul;136(1):5-6. doi: 10.1309

No abstract is available.

PMID: 21685025

View the full article at American Journal of Clinical Pathology>